The American Heart Association has launched AHA Ventures to invest in health tech and social impact.

Corporate investors rarely back sex startups but as attitudes change and the trend for sexual health and education picks up, are they missing out?

ÖAMTC will use the venture studio to explore new business areas related to the demographic change of its members.

CVC veteran Ricardo dos Santos has left ResMed and joined Takeda’s digital health investment arm as partner and head of its Venture Studio.

Merck Group’s CVC managing directors Owen Lozman and Hakan Goker speak about the transformational power of machine learning in pharma and materials science.

M Ventures' managing directors Hakan Goker and Owen Lozman explore the future of biotech and frontier technology.

From healthcare to fusion to quantum computing to space, superconductors have the potential to revolutionise the world. And the technology is finally ready to commercialise.

Venture capital firm Bioluminescence Ventures emerges from stealth with two funds supported by institutional investors.

Ben Jacobs of Companion Fund, flush with $300m from Mars, is going against the grain and betting bigger on startups as others pull back.

After serving two years at Grifols Innovation and New Technologies, Gasol Escuer has accepted a new position at global venture firm AdBio Partners